Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria V Babak

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Dalton Transactions (Cambridge, England : 2003)|May 21, 2020
Highly cytotoxic gold(i)-phosphane dithiocarbamate complexes trigger an ER stress-dependent immune response in ovarian cancer cellsHai Van Le, Maria V Babak, Muhammad Ali Ehsan, et al.
Inorganic Chemistry|June 17, 2022
Elucidation of Structure-Activity Relationships in Indolobenzazepine-Derived Ligands and Their Copper(II) Complexes: the Role of Key Structural Components and Insight into the Mechanism of ActionIrina Kuznetcova, Felix Bacher, Samah Mutasim Alfadul, et al.
Angewandte Chemie (International Ed. in English)|April 5, 2019
Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced NephrotoxicityMaria V Babak, Yang Zhi, Bertrand Czarny, et al.
Pharmaceutics|November 27, 2025
Bis-Oxadiazole Assemblies as NO-Releasing Anticancer AgentsEgor M Matnurov, Irina A Stebletsova, Alexander A Larin, et al.
Biomolecules|July 2, 2021
Coumarin-Based Triapine Derivatives and Their Copper(II) Complexes: Synthesis, Cytotoxicity and mR2 RNR Inhibition ActivityIryna Stepanenko, Maria V Babak, Gabriella Spengler, et al.
Journal of Medicinal Chemistry|November 10, 2025
Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum ChemotherapyDarren F Beirne, Jemma Arakelyan, Matteo Forner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 24, 2013
Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug developmentMaria V Babak, Samuel M Meier, Anton A Legin, et al.
Inorganic Chemistry|March 18, 2020
Heteroleptic Ruthenium(II) Complexes with Bathophenanthroline and Bathophenanthroline Disulfonate Disodium Salt as Fluorescent Dyes for In-Gel Protein StainingMaria V Babak, Pauline Le Faouder, Xavier Trivelli, et al.
International Journal of Molecular Sciences|February 25, 2023
Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in PlateletsOlga Zharkova, Maryam F Salamah, Maria V Babak, et al.
Chembiochem : a European Journal of Chemical Biology|April 12, 2023
Toward "E-Ring-Free" Lamellarin Analogues: Synthesis and Preliminary Biological EvaluationDaniil A Rusanov, Samah Mutasim Alfadul, Ekaterina Yu Portnyagina, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Dalton Transactions (Cambridge, England : 2003)|May 21, 2020
Highly cytotoxic gold(i)-phosphane dithiocarbamate complexes trigger an ER stress-dependent immune response in ovarian cancer cellsHai Van Le, Maria V Babak, Muhammad Ali Ehsan, et al.
Inorganic Chemistry|June 17, 2022
Elucidation of Structure-Activity Relationships in Indolobenzazepine-Derived Ligands and Their Copper(II) Complexes: the Role of Key Structural Components and Insight into the Mechanism of ActionIrina Kuznetcova, Felix Bacher, Samah Mutasim Alfadul, et al.
Angewandte Chemie (International Ed. in English)|April 5, 2019
Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced NephrotoxicityMaria V Babak, Yang Zhi, Bertrand Czarny, et al.
Pharmaceutics|November 27, 2025
Bis-Oxadiazole Assemblies as NO-Releasing Anticancer AgentsEgor M Matnurov, Irina A Stebletsova, Alexander A Larin, et al.
Biomolecules|July 2, 2021
Coumarin-Based Triapine Derivatives and Their Copper(II) Complexes: Synthesis, Cytotoxicity and mR2 RNR Inhibition ActivityIryna Stepanenko, Maria V Babak, Gabriella Spengler, et al.
Journal of Medicinal Chemistry|November 10, 2025
Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum ChemotherapyDarren F Beirne, Jemma Arakelyan, Matteo Forner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 24, 2013
Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug developmentMaria V Babak, Samuel M Meier, Anton A Legin, et al.
Inorganic Chemistry|March 18, 2020
Heteroleptic Ruthenium(II) Complexes with Bathophenanthroline and Bathophenanthroline Disulfonate Disodium Salt as Fluorescent Dyes for In-Gel Protein StainingMaria V Babak, Pauline Le Faouder, Xavier Trivelli, et al.
International Journal of Molecular Sciences|February 25, 2023
Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in PlateletsOlga Zharkova, Maryam F Salamah, Maria V Babak, et al.
Chembiochem : a European Journal of Chemical Biology|April 12, 2023
Toward "E-Ring-Free" Lamellarin Analogues: Synthesis and Preliminary Biological EvaluationDaniil A Rusanov, Samah Mutasim Alfadul, Ekaterina Yu Portnyagina, et al.
Pageof 6